You are here: Industry Insights > BD

News List

BD to Build $200M PFS Mfg. Facility in Spain contractpharma
May 19, 2021
New site is part of a $1.2 billion investment over four years to expand and upgrade manufacturing capacity and technology for pre-fillable syringes.
FDA Advises Health Care Professionals Not to Use ChloraPrep 3 mL BD Applicators americanpharmaceuticalreview
March 26, 2021
The U.S. Food and Drug Administration (FDA) advises health care professionals not to use ChloraPrep 3 mL applicators manufactured by BD (Becton, Dickinson and Company), due to microbial contamination risks.
BD to Invest in Pre-Fillable Syringe Manufacturing Capacity americanpharmaceuticalreview
December 21, 2020
BD announced plans to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing ...
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years prnasia
December 03, 2020
BD, a leading global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems ...
BD Receives FDA Approval for HPV Test with Extended Genotyping Capabilities americanpharmaceuticalreview
July 29, 2020
BD has received approval for a pre-market approval (PMA) supplement from the U.S. Food and Drug Administration (FDA) for an expanded version of its BD Onclarity™ HPV Assay.
BD Partners with U.S. Govt. on $70M Vaccination Program contractpharma
July 14, 2020
Company finalizes initial pandemic order for 50 million injection devices to support Operation Warp Speed vaccination program.
BD Announces Second FDA Emergency Use Authorization, CE Mark for COVID-19 Molecular Diagnostic americanpharmaceuticalreview
April 16, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for an additional molecular diagnostic test for COVID-19.
BD, BioGX Announce FDA Emergency Use Authorization for COVID-19 Diagnostic Test americanpharmaceuticalreview
April 08, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen ...
Dense Breast Notifications May Not Be Having Intended Impact drugs
December 31, 2019
While dense breast notifications (DBNs) are mandated legislatively in more than 35 states, they may not be having their intended impact ...
Particle Measuring Systems Announces Distribution Agreement with BD americanpharmaceuticalreview
December 09, 2019
Particle Measuring Systems (PMS) has announced a distribution agreement with BD (Becton, Dickinson and company)...

Previous page 1 2 3 Next page